articleJournal of BiotechnologyMay 21, 2015HYBRID OA

Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection

Thermo Fisher Scientific (United States)

PubMed
Indexed incrossrefpubmed

Abstract

CRISPR-Cas9 systems provide a platform for high efficiency genome editing that are enabling innovative applications of mammalian cell engineering. However, the delivery of Cas9 and synthesis of guide RNA (gRNA) remain as steps that can limit overall efficiency and ease of use. Here we describe methods for rapid synthesis of gRNA and for delivery of Cas9 protein/gRNA ribonucleoprotein complexes (Cas9 RNPs) into a variety of mammalian cells through liposome-mediated transfection or electroporation. Using these methods, we report nuclease-mediated indel rates of up to 94% in Jurkat T cells and 87% in induced pluripotent stem cells (iPSC) for a single target. When we used this approach for multigene targeting in…

Citation impact

749
total citations
FWCI
29.81
Percentile
100%
References
22
Citations per year

Authors

12

Topics & keywords

Keywords
  • Cas9
  • CRISPR
  • Transfection
  • Genome engineering
  • Guide RNA
  • Genome editing
  • Electroporation
  • Jurkat cells
UN Sustainable Development Goals
  • Industry, innovation and infrastructure
No related works found for this paper.